Evaluation of naphthalmustine, a nitrogen mustard derivative of naphthalimide as a rationally-designed anticancer agent

Journal of Experimental and Clinical Cancer Research

Volumn 22, Issue 3, 2003, Pages 411-418

  Pain, A ^a   Samanta, S ^a   Dutta, S ^a   Saxena, A K ^b   Shanmugavel, M ^b   Kampasi, H ^b   Qazi, G N ^b   Sanyal, U ^a  

^a CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

^b CSIR INDIAN INSTITUTE OF INTEGRATIVE MEDICINE   (India)

Author keywords

EAC; Human tumour lines; Mice; New anticancer agent; S 180; Screening

Indexed keywords

ANTINEOPLASTIC AGENT; CHLORMETHINE DERIVATIVE; CYCLOPHOSPHAMIDE; MITONAFIDE; NAPHTHALMUSTINE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW; CANCER REGRESSION; CANCER SURVIVAL; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; DRUG EFFICACY; DRUG SYNTHESIS; EHRLICH ASCITES TUMOR; EVALUATION; HEMATOPOIESIS; LD 50; LIVER TOXICITY; MOUSE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RIBONUCLEIC ACID SYNTHESIS INHIBITION; RNA SYNTHESIS; SARCOMA 180; SURVIVAL TIME; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; CELL DIVISION; CELL LINE, TUMOR; DRUG DESIGN; HUMANS; ISOQUINOLINES; MALE; MICE; MOLECULAR STRUCTURE; NEOPLASM TRANSPLANTATION; NITROGEN MUSTARD COMPOUNDS; SURVIVAL RATE;

EID: 0141670379     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Tew K.D., Colvin O.M., Chabner B.A.: Alkylating agents, In: Chabner B.A. and Longo D.L. eds Cancer Chemotherapy and Biotherapy- Principles and Practice., Philadelphia, Lippincot Williams & Wilkins. 2001, 373 and the references cited therein.
2. Tercel M., Lee A.E., Hogg A., Anderson R.F., Lee H.H., Siim B.G., Denny W.A., Wilson W.R.: Hypoxia-selective antitumour agents. 16. Nitroarylmethyl quaternary, salts as bioreductive prodrugs of the alkylating agent mechlorethamine. J. Med. Chem. 44: 3511-3522, 2001 and the references cited therein.
3. Brana M.F., Sanz A.M., Castellano J.M., Roldan C.M., Roldan C.: Synthesis and cytostatic activity of benz(de)isoquinolin-1,3-diones. Structure activity relationships. Eur J. Med. Chem. 16: 207-212, 1981.
4. Brana M.F., Castellano J.M., Roldan C.M., Santos A., Vazquez D., Jimenez A.: Synthesis and mode(s) of action of a new series of imide derivatives of 3-nitro-1,8-naphthalic acid. Cancer Chemother. Pharmacol. 4: 61-66, 1980.
5. Rosell R., Carles J., Abad A., Ribelles N., Barnadas A., Benavides A., Martin M.: Phase I study of Mitonafide in 120 hour continuous infusion in non-small cell lung cancer. Invest New Drugs. 10: 171-175, 1992.
6. Samanta S., Pain A., Dutta S., Sanyal U.: Evaluation of Naphthal-NU, a 2-chloroethylnitrosourea derivative of naphthalimide as a mixed-function anticancer agent. J. Exp Clin. Cancer Res. 21: 87-91, 2002.
7. Luning U., Mc. Bain S. D., Skell S. P.: Free radical addition of N-Bromoglutazimides and N-Bromophthalimide to alkenes. Absolute and relative rates. J. Org. Chem. 51: 2077-2080, 1986.
8. Geran R.I., Greenberg N.H., MacDonald M.M., Schumacher A.M., Abbott B.J.: Protocols for screening chemical agents and natural products against animal tumours and other biological systems. Cancer Chemother. Rep. Part. 3. 3: 1-103, 1972.
9. Mauck J.C., Davis J.E.: Clinical Enzymology. In: Sonnewirth A.C., Jarett L., eds Gradwohl's Clinical Laboratory Methods and Diagnosis. St. Louis, CV Mosby. 305-323, 1980.
10. Panda C.K., Chowdhury K., Sanyal U., Chakraborti S.K.: Mechanism of action of alpha-methylene-gamma-lactone derivatives of substituted nucleic acid bases in tumour cells. Chemotherapy 35: 174-180, 1989.
11. Dasgupta P.S., Lahiri T.: Antitumour effect of i.p. dopamine in mice bearing Ehrlich ascites carcinoma. J. Cancer Res. Clin. Oncol. 113: 363-368, 1987.
12. Skehan P., Storeng R., Scudiero D., Monks A., Mcmahon J., Vistica D., Warren J.T., Bokesch H., Kenney S., Boyd M.R.: New colorimetric cytotoxicity assay for anti-cancer drug screening. J. Natl. Cancer Inst. 82: 1107-1112, 1990.
13. Wheeler G.P., Chumley S.: Alkylating activity of 1,3-bis(2-chloroethyl)-1-nitrosourea and related compounds. J. Med. Chem. 10: 259-261, 1967.
14. Grochow L.B.: Covalent DNA-Binding Drugs. Cyclophosphamide. In: Perry M.C., ed The Chemotherapy Source Book. 2nd Edition. Baltimore, Williams & Wilkins. 297-299, 1996.